Table: begin end state 1 24 cytoplasmic 25 46 transmembrane 47 60 non-cytoplasmic 61 86 transmembrane 87 97 cytoplasmic 98 119 transmembrane 120 120 non-cytoplasmic 121 121 transmembrane 122 124 non-cytoplasmic 125 151 transmembrane 152 164 cytoplasmic 165 185 transmembrane 186 196 non-cytoplasmic 197 216 transmembrane 217 250 cytoplasmic 251 269 transmembrane 270 288 non-cytoplasmic 289 306 transmembrane 307 317 cytoplasmic 318 339 transmembrane 340 346 non-cytoplasmic 347 368 transmembrane 369 380 cytoplasmic 381 402 transmembrane 403 412 non-cytoplasmic 413 432 transmembrane 433 449 cytoplasmic
Input: >H281DRAFT_04512 MQTVMQAVTPAAAAPPLSRSQMRRAVLASVIGNGLEWFDFLIYGYFAKVIAQVYFPANNS FVSITLTLATFAIGFLVRPLGGIVIGACADRYGRRKTLSLLILLMALSTLMMGLTPGYAT IGIAAPLIVIVARILQGLSVGGEFATAAAMLTEYAPPRRKMFFGSFQMTSQAVALLLSSL CALLLTTRLSHESLVSWGWRVPFLLGALVGPVGFYIRHKVGESPEFLQLRERLGHAPRQS LRTFIRERGDAALCAMGVIIVGAATNYLWHSYMPLYVEHQLHLPLKNALFGTAISGLIGI AGYPLAGRLADRFGAYRLFFPVAIAWVCVAYPLFAWVLAAPSAERVFTAQMIATVVLSLM SGAHPGMLTQLFPTSTRSTGVALSYNVAVTLFGGLAPLTVSTLIDVTGSRLVPAWYLICA GVISLLLVGLTASGRRLVRKPDLWLADGQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server